• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KINETIC CONCEPTS, INC V.A.C. WHITEFOAM DRESSING; OMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KINETIC CONCEPTS, INC V.A.C. WHITEFOAM DRESSING; OMP Back to Search Results
Model Number VACDSP
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Foreign Body Reaction (1868); Foreign Body In Patient (2687); Swelling/ Edema (4577)
Event Date 03/30/2021
Event Type  Injury  
Manufacturer Narrative
Date of event: the first date of onset is unknown.It was reported the patient was admitted to hospital on (b)(6) 2021 and had stated to notice an increase in swelling, redness and drainage over the past few days.Thus, (b)(6) 2021 was utilized.V.A.C.Whitefoam¿ dressing lot number was not available and the dressing was not returned; therefore, a device history record review and a device evaluation could not be performed.Based on information provided, kci cannot determine when the foreign material alleged to be v.A.C.® dressing was placed in the wound.The patient was utilizing both v.A.C.Whitefoam¿ dressing and v.A.C.® granufoam¿ dressing.Additionally, kci is unable to determine if the alleged increase in swelling, redness and drainage are related to the v.A.C.Whitefoam¿ dressing.The foreign material was not returned to kci for identification; therefore, kci is unable to confirm its identity.The patient discontinued v.A.C.® therapy on (b)(6) 2021.The foreign material was allegedly left in the wound for over the manufacturer's recommendations.This event is being reported as a potential use error.Device labeling, available in print and online, states: warning: never leave a v.A.C.® dressing in place without active v.A.C.® therapy for more than two hours.If therapy is off for more than two hours, remove the old dressing and irrigate the wound.Either apply a new v.A.C.® dressing from an unopened sterile package and restart v.A.C.® therapy; or apply an alternate dressing, such as a wet to moist gauze, as approved during times of extreme need, by treating physician.Foam placement: always use v.A.C.® dressings from sterile packages that have not been opened or damaged.Do not place any foam dressing into blind / unexplored tunnels.The v.A.C.® whitefoam¿ dressing may be more appropriate for use with explored tunnels.Do not force foam dressings into any area of the wound, as this may damage tissue, alter the delivery of negative pressure or hinder exudate and foam removal.Always count the total number of pieces of foam used in the wound.Document the foam quantity and dressing change date on the drape or foam quantity label if available, and in the patient's chart.Foam removal: v.A.C.® foam dressings are not bioabsorbable.Always count the total number of pieces of foam removed from the wound and ensure the same number of foam pieces are removed as were placed.Foam left in the wound for greater that the recommended time period may foster ingrowth of tissue into the foam, create difficulty in removing the foam from the wound or lead to infection or other adverse events.If dressing adheres to wound consider introducing sterile water or normal saline into the dressing, waiting 15 - 30 minutes, then gently removing the dressing from the wound.Regardless of treatment modality, disruption of the new granulation tissue during any dressing change may result in bleeding at the wound site.Minor bleeding may be observed and considered expected.However, patients with increased risk of bleeding, as described on page 8, have a potential for more serious bleeding from the wound site.As a precautionary step, consider using v.A.C.Whitefoam¿ dressings or nonadherent material underneath the v.A.C.® granufoam¿ dressings to help minimize the potential for bleeding at dressing removal in these patients.
 
Event Description
On 07-apr-2021, the following clinical records from the hospital were reviewed by kci: on (b)(6) 2021, the patient was admitted to the hospital for abdominal wall drainage and pain.It was noted that v.A.C.® therapy was recently discontinued but the wound had not completely closed and was still draining.Over the past few days, the patient started noticing increased swelling, redness, and drainage from her abdominal wound in the periumbilical area.The patient was admitted for an excisional debridement.On (b)(6) 2021, the patient underwent an excisional debridement of a chronic non-healing abdominal wound and three pieces of foreign material alleged to be v.A.C.® dressing were identified and surgically excised.Per kci records the patient was discontinued from v.A.C.® therapy on (b)(6) 2021 and the patient was utilizing both v.A.C.Whitefoam¿ dressing and v.A.C.® granufoam¿ dressing.No additional information available.The v.A.C.Whitefoam¿ dressing and v.A.C.® granufoam¿ dressing lot numbers were not available, and the products were not returned; therefore, device history reviews and device evaluations could not be performed.Refer to mdr 3009897021-2021-00106 for the v.A.C.® granufoam¿ dressing.Refer to mdr for the v.A.C.Whitefoam¿ dressing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
V.A.C. WHITEFOAM DRESSING
Type of Device
OMP
Manufacturer (Section D)
KINETIC CONCEPTS, INC
san antonio TX 78249
Manufacturer Contact
steven jackson
6203 farinon drive
san antonio, TX 78249
2102556438
MDR Report Key11777673
MDR Text Key264521733
Report Number3009897021-2021-00100
Device Sequence Number1
Product Code OMP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133276
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician Assistant
Type of Report Initial
Report Date 05/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberVACDSP
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/07/2021
Initial Date FDA Received05/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient Weight80
-
-